Abstract Experimental cerebral ischemic stroke is exacerbated by inflammatory T-cells and is accompanied by systemic increases in CD4
Introduction
Stroke is a leading cause of death and the most frequent cause of permanent disability worldwide (Sacco et al. 2007 ). Severe brain ischemia causes an initial inflammatory phase in both the CNS and periphery, followed by severe immunosuppression that predisposes to life-threatening infections (Dirnagl et al. 2007) . Immunoregulatory mechanisms may limit the inflammatory phase as well as mediate immunosuppression. We demonstrated previously that naturally-occurring CD4 + CD25 +
Foxp3
+ regulatory Tcells (Sakaguchi et al. 2006 ) increase after cerebral ischemia in the face of massive depletion of other immunocytes from spleen and thymus (Offner et al. 2006b) . A recent report (Liesz et al. 2009) indicates that depletion of the CD25 + population with anti-CD25 mAb significantly increased brain infarct volume and worsened functional outcome after brief focal cerebral ischemia. These effects were attributed to CD4 + CD25 +
+ Treg cells, even though the anti-CD25 mAb only depleted~50% of this Treg phenotype. CD25, the IL-2 receptor chain-α (IL-2Rα), has a broad expression on early progenitors of the T-and B-cell lineages, as well as on activated mature T-cells and B-cells, thus allowing for the possible contribution of other regulatory cell types in the Liesz experiments besides Foxp3 + Treg. To target Treg more specifically, we employed the Foxp3 DTR mouse, in which the coding sequence of diphtheria toxin receptor (DTR) has been inserted into the foxp3 allele and is co-expressed on Foxp3+ cells (Kim et al. 2007 ). We tested the hypothesis that Treg are beneficial to the brain stressed with a standard model of middle cerebral ischemia (MCAO).
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Methods
Animals Mice used for these experiments were agematched males and females (7-11 weeks old) that were rested for at least 7 days before treatment. Foxp3 DTR mice, which were backcrossed with C57BL/6 (B6) mice, were generously provided by Dr. Alexander Rudensky (Kim et al. 2007 ). Animals were bred and cared for according to institutional guidelines in the animal resource facility at the Veterans Affairs Medical Center, Portland, OR.
Cell isolation Peripheral blood mononuclear cells were prepared by using red cell lysis buffer (eBioscience) following manufacturer's Instructions. Single-cell suspensions from lymph nodes (superficial cervical, mandibular, axillary, lateral axillary, superficial inguinal and mesenteric) and spleens were prepared by mechanical disruption. The cells were then washed twice with RPMI 1640, counted, and resuspended in stimulation medium containing 10% FBS for phenotyping.
Analysis of cell populations by FACS Single-cell suspensions were washed with staining medium (PBS containing 0.1% NaN3 and 2% FCS) and stained with mouse regulatory T cell staining kit (FJK-16s, eBioscience) according to manufacturer's instructions. After incubation with mAb and washing, cells were analyzed with a FACSCalibur (BD Biosciences). For each experiment, cells were stained with appropriate isotype control antibodies to establish background staining and to set quadrants before calculating the percentage of positive cells. Data were analyzed using Flowjo software (TreeStar).
MCAO The mice were subjected to middle cerebral artery occlusion (MCAO) as previously published (Offner et al. 2006a, b) by reversible right MCA occlusion (60 min) under isoflurane anesthesia, followed by 96 h of reperfusion. Body and head temperatures were controlled at 37± 0.5°C. Occlusion and reperfusion were verified in each animal by laser Doppler flowmetry (Moor Instruments).
Neurological deficit score Each mouse was scored on emergence from anesthesia and daily after MCAO as previously described (Offner et al. 2006b ). The graded scoring system ranges from 0 to 2 or 0 to 5 depending on the behavior, with 0 indicating no deficit and positive integers indicating impairment. Consciousness (0-3), interaction (0-2), eye appearance (0-2), breathing (0-2), food/ water intake (0-2), ability to clasp (0-2), motor function (0-5) and activity (0-2) were assessed.
Quantification of infarct As previously published (Offner et al. 2006a, b) , brains were collected at 96 h for standard 2,3,5-triphenyltetrazolium chloride (TTC) histology and digital image analysis of infarct volume. To control for edema, volume is expressed as a percentage of contralateral structure, i.e. cortex, striatum or total hemisphere.
Results
We accomplished near complete deletion of Foxp3 expression in the peripheral blood, lymph nodes and spleens (≤0.3%) by treating the mice with two daily i.p. injections of 50 μg diphtheria toxin (DT) per kg body weight (Fig. 1a) prior to induction of MCAO for 60 min on Day 3, followed by a final DT treatment on Day 4 that maintained deletion of Foxp3 + Treg as assessed on Day 7 (Fig. 1b) . In comparison, normal levels of Foxp3 + Treg cells were observed in vehicle-treated Foxp3 DTR mice undergoing MCAO (Fig. 1) .
Depletion of Foxp3 + Treg did not affect infarct volume in cortex or striatum in male, female or pooled male and female mice 96 h after MCAO and reperfusion (outline in Fig. 2a ) compared to vehicle treated mice (Fig. 2b, c & d) . Moreover, there were no significant effects of Treg depletion on behavioral evaluations (data not shown).
Discussion
These data show that Treg did not limit brain damage or improve functional outcomes in mice undergoing MCAO. We believe that there are at least two plausible explanations that account for the different outcomes in our study vs. the single previous evaluation of Treg cells in cerebral ischemia. First, we selectively depleted essentially all Foxp3-expressing cells using a genetic approach. In Liesz et al., 
Foxp3
+ Treg as a possible therapeutic approach in stroke. Our results do not support this rationale, but do highlight the need to identify other regulatory pathways that can limit stroke-induced inflammatory damage to the CNS.
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